Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Brii Biosciences Limited ( (HK:2137) ) has shared an update.
Brii Biosciences Limited has announced its upcoming annual general meeting (AGM) scheduled for June 3, 2025, to be held online. The AGM will address several key resolutions, including the adoption of the company’s financial statements for 2024, re-election of directors, and re-appointment of Deloitte Touche Tohmatsu as the auditor. Additionally, the meeting will consider resolutions to authorize the board to manage share allotments and other related powers, which could impact the company’s capital structure and shareholder value.
More about Brii Biosciences Limited
Brii Biosciences Limited operates in the biotechnology industry, focusing on developing innovative therapies for infectious diseases and central nervous system disorders. The company aims to address significant unmet medical needs and improve patient outcomes through its research and development efforts.
YTD Price Performance: 65.83%
Technical Sentiment Signal: Sell
Current Market Cap: €153.8M
Find detailed analytics on 2137 stock on TipRanks’ Stock Analysis page.